The first issue of the European Health & Pharmaceutical Law Review (EHPL) for 2025 is now available! This edition features a selection of thought-provoking articles and reports on critical developments in health and pharmaceutical law.
Articles:
Exploring the balance between intellectual property protection and the right to scientific progress in cancer research.
An in-depth look at the risks and regulatory challenges of off-label drug use in the EU, with fluoroquinolones as a case study.
Regulatory Sandbox to Support Innovation in the Pharmaceutical Field
An examination of about how regulatory sandboxes can accelerate the development of innovative medicines by providing a controlled environment for testing, fostering collaboration between regulators and industry, and expediting patient access to treatments.
This issue also includes the following reports:
From Lab to Market: The EU AI Act’s Impact on Pharmaceutical AI Deployers
A New Reimbursement Law in Poland Is Forthcoming – Will It Enhance Access to Medicines?
View all articles from the latest issue of EHPL here.
Become an author for EHPL and view our Call for Papers.